1 Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
2 Berta-Ottenstein-Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
3 Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
4 Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany.
5 AC Immune, Lausanne, Switzerland.
6 Department of Neurosurgery, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
7 Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany. gruen@ie-freiburg.mpg.de.
8 Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg im Breisgau, Germany. gruen@ie-freiburg.mpg.de.
9 Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany. josef.priller@charite.de.
10 DZNE and BIH, Berlin, Germany. josef.priller@charite.de.
11 University of Edinburgh and UK DRI, Edinburgh, UK. josef.priller@charite.de.
12 Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. marco.prinz@uniklinik-freiburg.de.
13 Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg im Breisgau, Germany. marco.prinz@uniklinik-freiburg.de.
14 Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. marco.prinz@uniklinik-freiburg.de.